Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-02-26 @ 4:13 PM
Study NCT ID:
NCT00126568
Status:
TERMINATED
Last Update Posted:
2018-01-19
First Post:
2005-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-02
First Submit QC Date:
None
Study First Post Date:
2005-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-23
Results First Submit QC Date:
None
Results First Post Date:
2012-08-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-20
Last Update Post Date:
2018-01-19
Last Update Post Date Type:
ACTUAL